Analysis of the reasonability of the use of intravenous proton pump inhibitors and its in-hospital control
Objective:To investigate the reasonability of the use of intravenous proton pump inhibitors(PPIs)in our hospital.Methods:The cases using PPIs in our hospital in 2022 were collected,and a total of 226 medical records met the requirements.Results:The PPI injections with the highest number of times listed in the top five quarterly amounts were in order esomeprazole,eprazole,rabeprazole and omeprazole.The unreasonable rate in the 226 medical records accounted for 64.16%,of which 53 cases(36.55%)were used without indications,46 cases(31.72%)were not suitable for dose,21 cases(14.48%)were not suitable for the course of treatment,and 17 cases were not suitable for drug selection(11.72%),5 cases(3.45%)were not suitable for combination,3 cases(2.07%)were not suitable for solvent.Conclusion:The phenomenon of unreasonable use of PPIs requires strengthening the control of key varieties and improving the level of rational medication among physicians so as to promote rational medication.
proton pump inhibitorsrational drug usemanagement and control